Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Outcomes Matter Innovations, LLC ("OMI") today announced the addition of seasoned healthcare executive, Paul Marchetti, to their Board of Directors. Marchetti brings expertise from all sides of the ...

Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...

The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...

A patient with prescription benefits who is visiting a pharmacy may also be someone involved in the payer's decision process regarding a PBM. Or the patient may be an employer. Pharmacists can ...

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

No one defines these problem and their solutions better than Elizabeth Mitchell. As president and CEO of Purchaser Business Group on Health (PBGH), Mitchell leads a nonprofit coalition representing 40 ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations ... lower than that observed across all other payer segments nationally." Dr. Pragya Kakani ...